Estimating the market size for a dual prevention pill: adding contraception to pre-exposure prophylaxis (PrEP) to increase uptake

por Begg, Lorna, Brodsky, Rebecca, Friedland, Barbara, Mathur, Sanyukta, Sailer, Jim, Creasy, George
Publicado 2021

First-in-Human Trial of MIV-150 and Zinc Acetate Coformulated in a Carrageenan Gel: Safety, Pharmacokinetics, Acceptability, Adherence, and Pharmacodynamics

por Friedland, Barbara A., Hoesley, Craig J., Plagianos, Marlena, Hoskin, Elena, Zhang, Shimin, Teleshova, Natalia, Alami, Mohcine, Novak, Lea, Kleinbeck, Kyle R., Katzen, Lauren L., Zydowsky, Thomas M., Fernández-Romero, José A., Creasy, George W.
Publicado 2016

Efficacy of the 1-year (13-cycle) segesterone acetate and ethinylestradiol contraceptive vaginal system: results of two multicentre, open-label, single-arm, phase 3 trials

por Archer, David F, Merkatz, Ruth B, Bahamondes, Luis, Westhoff, Carolyn L, Darney, Philip, Apter, Dan, Jensen, Jeffrey T, Brache, Vivian, Nelson, Anita L, Banks, Erika, Bártfai, György, Portman, David J, Plagianos, Marlena, Dart, Clint, Kumar, Narender, Creasy, George W, Sitruk-Ware, Regine, Blithe, Diana L
Publicado 2019

Results of a phase 1, randomized, placebo-controlled first-in-human trial of griffithsin formulated in a carrageenan vaginal gel

por Teleshova, Natalia, Keller, Marla J., Fernández Romero, José A., Friedland, Barbara A., Creasy, George W., Plagianos, Marlena G., Ray, Laurie, Barnable, Patrick, Kizima, Larisa, Rodriguez, Aixa, Cornejal, Nadjet, Melo, Claudia, Cruz Rodriguez, Gearoff, Mukhopadhyay, Sampurna, Calenda, Giulia, Sinkar, Shweta U., Bonnaire, Thierry, Wesenberg, Asa, Zhang, Shimin, Kleinbeck, Kyle, Palmer, Kenneth, Alami, Mohcine, O’Keefe, Barry R., Gillevet, Patrick, Hur, Hong, Liang, Yupu, Santone, Gabriela, Fichorova, Raina N., Kalir, Tamara, Zydowsky, Thomas M.
Publicado 2022